Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -46.73% | -3.36% | 84.55% | 91.73% | 98.10% |
| Total Revenue | -46.73% | -3.36% | 84.55% | 91.73% | 98.10% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -46.73% | -3.36% | 84.55% | 91.73% | 98.10% |
| SG&A Expenses | 10.56% | 7.40% | 4.07% | 6.32% | 7.29% |
| Depreciation & Amortization | -0.07% | -1.42% | -2.86% | -0.66% | 0.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.59% | -8.65% | -5.14% | 16.76% | 42.28% |
| Operating Income | -14.89% | 11.42% | 34.07% | 11.45% | -17.35% |
| Income Before Tax | -12.08% | 13.10% | 34.84% | 11.65% | -17.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.08% | 13.10% | 34.84% | 11.65% | -17.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.08% | 13.10% | 34.84% | 11.65% | -17.99% |
| EBIT | -14.89% | 11.42% | 34.07% | 11.45% | -17.35% |
| EBITDA | -15.27% | 11.66% | 34.76% | 11.72% | -17.87% |
| EPS Basic | 20.00% | 38.64% | 54.17% | 27.91% | -2.56% |
| Normalized Basic EPS | 16.67% | 37.04% | 53.33% | 29.63% | 4.00% |
| EPS Diluted | 20.00% | 38.64% | 54.17% | 27.91% | -2.56% |
| Normalized Diluted EPS | 16.67% | 37.04% | 53.33% | 29.63% | 4.00% |
| Average Basic Shares Outstanding | 37.04% | 36.10% | 35.04% | 28.11% | 20.69% |
| Average Diluted Shares Outstanding | 37.04% | 36.10% | 35.04% | 28.11% | 20.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |